首页|期刊导航|中国药物经济学|益气养阴类中药联合二甲双胍治疗2型糖尿病疗效与安全性的Meta分析

益气养阴类中药联合二甲双胍治疗2型糖尿病疗效与安全性的Meta分析OA

Meta-analysis of the Efficacy and Safety of Combining Metformin with Qi Nourishing and Yin Nourishing Herbs in the Treatment of T2DM

中文摘要英文摘要

目的 系统评价益气养阴类中药联合二甲双胍治疗 2 型糖尿病(T2DM)的疗效与安全性.方法 系统检索并收集Cochrane Library、Web of Science、PubMed、中国生物医学文献数据库、万方数据知识服务平台、中国期刊全文数据库、中文期刊全文数据库7 大数据库中关于益气养阴类中药联合二甲双胍治疗T2DM的临床随机对照试验(RCT)相关文献,限定时间为建库至 2025 年 1 月.遵照预设标准筛选文献,对文献总体质量进行评估,使用Review Manager 5.4 软件分析数据.结果 最终得到文献 15 篇,共 1 693 例患者,观察组(益气养阴类中药+二甲双胍)848 例、对照组(二甲双胍)845 例.Meta分析结果显示:观察组治疗总有效率明显高于对照组[RR=1.26,95%CI(1.20,1.32),P<0.000 01];同时,与对照组相比,观察组在空腹血糖(FPG)[MD=-1.00,95%CI(-1.30,-0.71),P<0.000 01]、餐后2 h血糖(2hPBG)[MD=-1.44,95%CI(-1.84,-1.04),P<0.000 01]、糖化血红蛋白(HbA1c)[MD=-0.82,95%CI(-0.99,-0.65),P<0.000 01]、中医证候积分[MD=-3.40,95%CI(-4.18,-2.62),P<0.000 01]、空腹胰岛素(FINS)[MD=-3.75,95%CI(-5.95,-1.56),P<0.000 1]、胰岛素抵抗指数(HOMA-IR)[MD=-1.03,95%CI(-1.59,-0.47),P=0.000 3]、甘油三酯(TG)[MD=-0.45,95%CI(-0.84,-0.06),P=0.02]、总胆固醇(TC)[MD=-0.79,95%CI(-1.20,-0.38),P=0.000 2]、低密度脂蛋白(LDL)[MD=-0.62,95%CI(-0.89,0.35),P<0.000 01]方面下降更明显而对升高高密度脂蛋白(HDL)[MD=0.26,95%CI(-0.03,0.55),P=0.08]更具优势.两组不良反应发生率比较,差异无统计学意义[RR=0.61,95%CI(0.30,1.21),P=0.16].结论 益气养阴类中药联合二甲双胍治疗T2DM的有效性优于单独使用二甲双胍,而两种治疗方式的安全性无明显差异.

Objective To systematically evaluate the efficacy and safety of qi-benefiting and yin-nourishing traditional Chinese medicine combined with metformin in the treatment of type 2 diabetes mellitus(T2DM).Methods A systematic search of seven major databases,Cochrane Library,Web of Science,PubMed,China Biomedical Literature Database,Wanfang,China Knowledge,and Wipro,was conducted to collect literature related to the clinical randomised controlled trials on the combination of qi nourishing and yin nourishing Chinese herbs with metformin for the treatment of T2DM,with a limited time period of the library construction to January 2025.The literature was screened according to preset criteria,the overall quality of the literature was assessed,and the data were analysed using Review Manager 5.4 software.Results Fifteen articles were obtained,with a total of 1 693 patients,848 in the observation group(qi and yin-boosting traditional Chinese medicine+metformin)and 845 in the control group(metformin).Meta-analysis results showed that,the total clinical effectiveness rate of the observation group was significantly higher than the control group[RR=1.26,95%CI(1.20,1.32),P<0.000 01].Meanwhile,compared with the control group,the observation group had significantly higher clinical efficacy rates in fasting glucose(FPG)[MD=-1.00,95%CI(-1.30,-0.71),P<0.000 01],2-hour postprandial glucose(2hPBG)[MD=-1.44,95%CI(-1.84,-1.04),P<0.000 01],and glycosylated haemoglobin(HbA1c)[MD=-0.82,95%CI(-0.99,-0.65),P<0.000 01],Chinese medicine evidence score[MD=-3.40,95%CI(-4.18,-2.62),P<0.000 01],fasting insulin(FINS)[MD=-3.75,95%CI(-5.95,-1.56),P<0.000 1],insulin resistance index(HOMA-IR)[MD=-1.03,95%CI(-1.59,-0.47),P=0.000 3],and triglycerides(TG)[MD=-0.45,95%CI(-0.84,-0.06),P=0.02],and serum total cholesterol(TC)[MD=-0.79,95%CI(-1.20,-0.38),P=0.000 2],and low-density lipoprotein(LDL)[MD=-0.62,95%CI(-0.89,0.35),P<0.000 01],whereas there was a more pronounced decrease in elevated high-density lipoprotein(HDL)[MD=0.26,95%CI(-0.03,0.55),P=0.08]was more favourable.The incidence of adverse events was not statistically significant in the two groups[RR=0.61,95%CI(0.30,1.21),P=0.16].Conclusion The efficacy of qi-benefiting and yin-nourishing herbs combined with metformin in the treatment of T2DM is superior to that of metformin alone,whereas there is no significant difference in the safety of the two treatment modalities.

徐婷;徐寒松;陈永华;宋国林;韦玄烨;吴燕梅;李霞;邓淋城

贵州中医药大学第二临床医学院,贵阳 550002贵州省第二人民医院代谢内分泌科,贵阳 550001贵州省第二人民医院代谢内分泌科,贵阳 550001贵州中医药大学第二临床医学院,贵阳 550002贵州中医药大学第二临床医学院,贵阳 550002贵州中医药大学第二临床医学院,贵阳 550002贵州中医药大学第二临床医学院,贵阳 550002贵州中医药大学第二临床医学院,贵阳 550002

医药卫生

益气养阴中药2型糖尿病二甲双胍对照研究Meta分析

Benefit qi and nourish yinTraditional Chinese medicineType 2 diabetes mellitusMetforminControlled studyMeta-analysis

《中国药物经济学》 2026 (1)

69-75,7

贵州省中医药管理局中医药、民族医药科学技术研究专项(QZYY-2025-040QZYY-2023-044)贵州省名中医石恩骏传承工作室建设项目(黔中药函[2024]38号)贵州中医药大学大创项目(贵中医大创合字[2022]55号)

10.12010/j.issn.1673-5846.2026.01.014

评论